- Trials with a EudraCT protocol (30)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
30 result(s) found for: Home ultrasound.
Displaying page 1 of 2.
EudraCT Number: 2009-014721-16 | Sponsor Protocol Number: IRRB/19/09 | Start Date*: 2009-11-18 |
Sponsor Name:ISTITUTO MEDITERRANEO PER I TRAPIANTI E TERAPIE AD ALTA SPECIALIZZAZIONE | ||
Full Title: Controlled randomized pilot study for characterization and identification of CD34+ stem cells in the splancnic distrect after GCSF stimolation in cirrhotic patients | ||
Medical condition: Liver cirrhosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2005-003099-39 | Sponsor Protocol Number: LWH0604 | Start Date*: 2008-08-21 |
Sponsor Name:Liverpool Women's NHS Foundation Trust Hospital | ||
Full Title: A Randomised Controlled Trial of Thyroxine in Preterm Infants Under 28 weeks' Gestation. | ||
Medical condition: Hypothyroidism is a condition where there is a lack of thyroid hormone in the body. Thyroid hormones are important for normal brain development and growth. Children who are born with low thyroid ho... | ||
Disease: | ||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-002595-82 | Sponsor Protocol Number: NL49853.094.14 | Start Date*: 2014-10-23 | |||||||||||
Sponsor Name:Westfriesgasthuis | |||||||||||||
Full Title: A randomised, double blind clinical trial comparison the effect of a ultrasound-guided transversus abdominis plane (TAP) block and wound infiltration on postoperative pain (48h) for open inguinal h... | |||||||||||||
Medical condition: Postoperative pain after hernia inguinalis repair surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-001217-16 | Sponsor Protocol Number: AT032012 | Start Date*: 2012-06-05 |
Sponsor Name:UZLeuven | ||
Full Title: Dorsal penile nerve block(DPNB) for circumcision: a comparison of ultrasound-guided vs. landmark technique. | ||
Medical condition: Postoperative pain and recovery after circumcision | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-000566-11 | Sponsor Protocol Number: 39-2018 | Start Date*: 2018-06-05 |
Sponsor Name:University of Oulu | ||
Full Title: Extremely low gestational age infants' PARAcetamol Study | ||
Medical condition: Open ductus arteriosus of a premature infant | ||
Disease: | ||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |
Trial protocol: FI (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2013-002359-14 | Sponsor Protocol Number: 1.0 | Start Date*: 2013-10-23 |
Sponsor Name:Medizinische Universität Wien, Universitätsklinik für Anästhesie, Allgemeine Intesnivmedizin und Schmerztherapie | ||
Full Title: Ultrasound Guided Caudal Blockade in Children between 30 and 50kg: A Feasibility Study | ||
Medical condition: Caudal block is a very well established method to anaesthesize children for lower body surgery until they have a body weight up to 25kg. We would like to prove that it is also possible to perfor... | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-003703-19 | Sponsor Protocol Number: 18-002 | Start Date*: 2020-04-20 |
Sponsor Name:RWTH Aachen University represented by the Rector himself, represented by the Dean of the Medical Faculty | ||
Full Title: The Effect of Higher Protein Dosing in Critically Ill Patients: A Multicenter Randomized Trial | ||
Medical condition: Nutritionally high-risk critically ill mechanically ventilated patients. In this sub-study, eligible and enrolled patients randomized to the high protein dose group will achieve its protein goals b... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2014-004478-41 | Sponsor Protocol Number: LCC001 | Start Date*: 2015-03-10 | |||||||||||
Sponsor Name:King's College London [...] | |||||||||||||
Full Title: Phase III trial in IntrahepaTic CHolestasis of pregnancy (ICP) to Evaluate urSodeoxycholic acid (UDCA) in improving perinatal outcomes | |||||||||||||
Medical condition: Intrahepatic Cholestasis of pregnancy | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-001396-33 | Sponsor Protocol Number: EPA-COV-001 | Start Date*: 2020-11-13 | |||||||||||
Sponsor Name:SLA Pharma (UK) Ltd [...] | |||||||||||||
Full Title: A randomised, double-blind, placebo-controlled study of eicosapentaenoic acid (EPA-FFA) gastro-resistant capsules to treat hospitalised subjects with confirmed SARS-CoV-2 | |||||||||||||
Medical condition: SARS-CoV-2 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-001998-24 | Sponsor Protocol Number: ME3827/1-1 | Start Date*: 2014-10-09 |
Sponsor Name:Saarland University | ||
Full Title: A prospective, multicenter, double blind, placebo-controlled, two-arm parallel group phase 3 trial to evaluate the effect of early postnatal additional high dose oral vitamin A supplementation of 5... | ||
Medical condition: Preventing bronchopulmonary dysplasia (BPD) or death in extremely-low-birth-weight (ELBW) infants. | ||
Disease: | ||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |
Trial protocol: DE (Completed) AT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2010-023988-17 | Sponsor Protocol Number: 260777 | Start Date*: 2014-04-04 | |||||||||||
Sponsor Name:BrepCo Biopharma Limited | |||||||||||||
Full Title: Management of Hypotension In the Preterm: A multi centre, randomised, controlled trial of hypotension management in the extremely low gestational age newborn | |||||||||||||
Medical condition: Low Blood Pressure | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Prematurely Ended) CZ (Prematurely Ended) BE (Prematurely Ended) GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-005229-95 | Sponsor Protocol Number: PBKR03-001 | Start Date*: 2021-08-23 | |||||||||||
Sponsor Name:Passage Bio, Inc. | |||||||||||||
Full Title: A Phase 1/2 Open-Label, Multicenter, Dose Ranging and Confirmatory Study to Assess the Safety, Tolerability and Efficacy of PBKR03 Administered to Pediatric Subjects with Early Infantile Krabbe Dis... | |||||||||||||
Medical condition: Krabbe disease (globoid cell leukodystrophy) is an autosomal recessive lysosomal storage disease (LSD) caused by mutations in the gene encoding the hydrolytic enzyme galactosylceramidase (galactoce... | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-001364-30 | Sponsor Protocol Number: BBH-TQL-LC | Start Date*: 2013-07-22 | |||||||||||
Sponsor Name:Bispebjerg Hospital | |||||||||||||
Full Title: Ultrasoundguided transmuscular quadrates lumborum block after elective laparoscopic cholecystectomy. A prospective, randomised clinical trial. | |||||||||||||
Medical condition: Postoperative pain following laparoscopic cholecystectomy | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-002170-34 | Sponsor Protocol Number: 2004-002170-34 | Start Date*: 2006-03-29 |
Sponsor Name:Cambridge University Hospital (Addenbrookes Hospital) | ||
Full Title: "Ensayo clínico controlado randomizado sobre el tratamiento precoz con insulina en recién nacidos de muy bajo peso" | ||
Medical condition: Very low birth weight infants requiring intensive care have relative insulin deficiency often leading to hyperglycaemia during the first week of life. There is increasing evidence that the early po... | ||
Disease: | ||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-000656-18 | Sponsor Protocol Number: 2042015 | Start Date*: 2018-11-09 | |||||||||||
Sponsor Name:SINTETICA SA | |||||||||||||
Full Title: Randomized, multi-center, double-blind, two-armed, parallel active groups, prospective trial, to evaluate, in pediatric population undergoing 'Calcaneo stop' surgery or Inguinal hernia repair, the ... | |||||||||||||
Medical condition: Pediatric patients undergoing surgery of flatfoot or inguinal hernia | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Trial now transitioned) ES (Restarted) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002519-40 | Sponsor Protocol Number: CHL.2/01-2014/M | Start Date*: 2015-08-17 | |||||||||||
Sponsor Name:Sintetica S.A. | |||||||||||||
Full Title: A prospective, randomised, non-inferiority study of Chloroprocaine 2% and the active control Ropivacaine 0.75% (AstraZeneca) in ultrasound-guided axillary nerve block for short-duration distal uppe... | |||||||||||||
Medical condition: Local anaesthesia by axillary nerve block | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-001405-32 | Sponsor Protocol Number: IMIS2017-02 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Institut des Maladies Génétiques - Imagine | |||||||||||||
Full Title: A Monocentric Single-arm study to characterize the long-term safety, efficacy, and pharmacodynamic of GLP-2 analog (Revestive®) in the management of short bowel syndrome pediatric patients on home-... | |||||||||||||
Medical condition: Short Bowel Syndrom | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001393-16 | Sponsor Protocol Number: SHP607-202 | Start Date*: 2019-06-21 | |||||||||||
Sponsor Name:Premacure AB | |||||||||||||
Full Title: A Phase 2b, Multicenter, Randomized, Open-label, Controlled, 3-Arm Study to Evaluate the Clinical Efficacy and Safety of SHP607 in Preventing Chronic Lung Disease Through 12 Months Corrected Age Co... | |||||||||||||
Medical condition: Chronic Lung Disease | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) IE (Trial now transitioned) SE (Prematurely Ended) FR (Completed) DE (Trial now transitioned) PT (Trial now transitioned) ES (Temporarily Halted) FI (Trial now transitioned) NL (Trial now transitioned) PL (Prematurely Ended) IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-004890-29 | Sponsor Protocol Number: FIT-PIV | Start Date*: 2023-03-09 | |||||||||||
Sponsor Name:Elgan Pharma Ltd | |||||||||||||
Full Title: A Multi-center, Double-Blind, Randomized, Two-Arm, Parallel-Group, Placebo Controlled Study to Assess the Efficacy and Safety of ELGN-2112 on Intestinal Malabsorption in Preterm Infants | |||||||||||||
Medical condition: Gastro-intestinal malabsorption due to gastro-intestinal immaturity in preterm infants. | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) ES (Ongoing) SE (Trial now transitioned) NL (Trial now transitioned) AT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-000849-23 | Sponsor Protocol Number: HC-G-H-1403 | Start Date*: 2017-08-21 | |||||||||||
Sponsor Name:B. Braun Melsungen AG | |||||||||||||
Full Title: A RANDOMIZED, CONTROLLED, DOUBLE-BLIND, MULTICENTER CLINICAL TRIAL ON HOME PARENTERAL NUTRITION USING AN OMEGA-3 FATTY ACID ENRICHED MCT/LCT LIPID EMULSION | |||||||||||||
Medical condition: Chronic intestinal failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
